John B. Henneman, III
2015 - NewLink Genetics
In 2015, John B. Henneman, III earned a total compensation of $818.4K as Chief Financial Officer & Secretary at NewLink Genetics, a 80% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,992 |
|---|---|
| Option Awards | $173,896 |
| Salary | $365,200 |
| Stock Awards | $87,300 |
| Other | $23,994 |
| Total | $818,382 |
Henneman received $365.2K in salary, accounting for 45% of the total pay in 2015.
Henneman also received $168K in non-equity incentive plan, $173.9K in option awards, $87.3K in stock awards and $24K in other compensation.
Rankings
In 2015, John B. Henneman, III's compensation ranked 8,873rd out of 13,638 executives tracked by ExecPay. In other words, Henneman earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,873 out of 13,638 | 35th |
Division Manufacturing | 3,384 out of 5,187 | 35th |
Major group Chemicals And Allied Products | 1,237 out of 1,857 | 33rd |
Industry group Drugs | 1,009 out of 1,531 | 34th |
Industry Pharmaceutical Preparations | 781 out of 1,179 | 34th |
Source: SEC filing on March 31, 2017.
Henneman's colleagues
We found five more compensation records of executives who worked with John B. Henneman, III at NewLink Genetics in 2015.
2015
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2015
Nicholas Vahanian
NewLink Genetics
Chief Medical Officer
2015
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2015
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2015
Carl Langren
NewLink Genetics